Archive February 2008
HOSPITAL
ACQUIRED INFECTION
|
|
|
What we know
What information do we have about the Eastern Board
area?
What is the result of this on our health locally?
Policies
What is happening in the Eastern Board area?
|
|
| What
we know |
| In recent years there
has been considerable concern about the frequency of infections
acquired by patients while they are in hospital. This is despite
improved methods of sterilisation of equipment and wider adoption
of aseptic techniques. The factors involved in this include:
 |
The emergence of resistant
strains of organisms, partly due to the increased used of antibiotics; |
 |
The increased survival of patients with
life threatening illnesses who are more susceptible to infection; |
 |
The wider use and complexity of surgical
procedures; |
 |
The advent of modern therapies, such
as immunosuppressive drugs, which lower resistance to infection. |
Back
to top |
| What information
do we have about the Eastern Board area? |
| The Communicable Disease
Surveillance Centre Northern Ireland records instances of Methicillin-resistant
Staphylococcus Aureus (MRSA). Between April 2004 and March 2005,
there were 242 patient episodes recorded of MRSA Bacteraemia in
Northern Ireland, 143 of which were in hospitals in the Eastern Board area. It
is important to note, however, that there is a concentration of
hospital Trusts in the Eastern Board area, many of which provide
regional services. This illustrates a reduction of 21% in Northern Ireland and from the same period in 2003/04
Back
to top |
| What is
the result of this on our health locally? |
| Urinary and wound infections,
that are especially likely to develop when a patient is in hospital,
tend to be endogenous (i.e. a break in the patient’s natural
body defences causes the patient’s own normal bacterial flora
to induce infection). Hospital acquired infections often increase
the length of stay in hospital with economic implications for the
individual and the health service.
One infection which has caused increased
concern recently is Methicillin-resistant Staphylococcus Aureus
(MRSA). The main problem with MRSA in the hospital setting is that
staff or patients who carry the bacteria represent a risk to other
patients. Staphylococcus aureus is a skin commensal which is carried
by about 30% of the population. All staphylococci, including MRSA,
are easily spread by direct contact and persist in the environment.
Where patients are being constantly moved between wards and from
nursing homes into hospital MRSA can spread very quickly. The primary
problem in hospital is therefore one of cross infection. MRSA can
cause deep-seated wound infections that prove very difficult to
treat. Hospital outbreaks of MRSA can be difficult to control. Effective
control measures include identifying and treating carriers, isolating
those with infection and strict adherence to stringent hygiene policies
in hospitals including rigorous environmental cleaning.
Back
to top |
| Policies |
| The
Department of Health in England has published various guidance and
established a range of national advisory structures and expert committees
to increase the priority given to hospital acquired infection. These
include “Winning Ways – Working together to reduce healthcare
infection in England – report from the CMO” (2003) and
“Towards cleaner hospitals and lowers rates of infection”
(2004).
The Welsh Assembly developed “Hospital associated
infections – A strategy for hospitals in Wales” (2004).
The Scottish Assembly developed “Preventing
infections acquired while receiving health care – the Scottish
Executive’s action plan to reduce the risk to patients, staff
and visitors 2002-2005”.
The National Institute for Clinical Excellence
(NICE) guidance on infection control makes recommendations on the
standard principles for preventing healthcare associated infections
and on measures for preventing infections (“Infection control:
prevention of healthcare-associated infection in primary and secondary
care”).
Back
to top |
| What is happening
in the Eastern Board area? |
| In
Northern Ireland an Infection Control Strategy is being developed.
Infection control is a high priority, with Trusts making improvements
to their infection control management arrangements to reduce the
risk of hospital acquired infection.
The Communicable Disease Surveillance Centre Northern Ireland, which
is part of the UK Health Protection Agency, provides a regional
service which includes:
 |
Surveillance of communicable disease; |
 |
Advice and support to DHSSPS,
Health and Social Services Boards and Trusts; |
 |
Advice and support to professionals; |
 |
Training and the promotion of professional
standards; |
 |
Research. |
At national level the Health Protection Agency (HPA), in association
with the NHS and other organisations:
 |
monitors and investigates the
occurrence of infection within the population; |
 |
provides specialist and reference laboratory
services for the detection of infectious agents in people, food
and the environment; |
 |
investigates outbreaks of disease and coordinates
the response to major epidemics or other infectious disease
emergencies; |
 |
provides authoritative information and advice
to government, professionals and the public; |
 |
manufactures vaccines and undertakes studies
of the safety and effectiveness of these and other products; |
 |
improves knowledge through research and development,
education and training. |
Back
to top |
|
For further information on this topic please contact us at publichealth@ehssb.n-i.nhs.uk
Eastern Health and Social Services Board Champion
House, 12-22 Linenhall Street, Belfast BT2 8BS Telephone: (028)
9032 1313 Fax: (028) 9055 3681 Text Phone:(028) 9032 4980 Website:
www.ehssb.org
E-mail: pr@ehssb.n-i.nhs.uk
Site designed by areema.co.uk |
| |